Form 8-K

8-K — Atlantic Union Bankshares Corp

Accession: 0001104659-26-087206

Filed: 2026-07-28

Period: 2026-07-27

CIK: 0000883948

SIC: 6022 (STATE COMMERCIAL BANKS)

Item: Entry into a Material Definitive Agreement

Item: Financial Statements and Exhibits

Documents

8-K — tm2621299d2_8k.htm (Primary)

EX-1.1 — EXHIBIT 1.1 (tm2621299d2_ex1-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm2621299d2_8k.htm · Sequence: 1

false

0000883948

2026-07-27

0000883948

us-gaap:CommonStockMember

2026-07-27

0000883948

us-gaap:SeriesAPreferredStockMember

2026-07-27

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities

Exchange Act of 1934

Date of Report (Date of earliest event reported):

July 27, 2026

ATLANTIC

UNION BANKSHARES CORPORATION

(Exact name of registrant as specified in its

charter)

Virginia

001-39325

54-1598552

(State or other jurisdiction

(Commission

(I.R.S. Employer

of incorporation)

File Number) Identification No.)

4300

Cox Road

Glen

Allen, Virginia 23060

(Address of principal executive offices, including

Zip Code)

Registrant’s telephone number, including

area code: (804) 633-5031

Check the appropriate box below if the Form 8-K filing is intended

to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.

below):

¨ Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Common

Stock, par value $1.33 per share

AUB

New

York Stock Exchange

Depositary

Shares, Each Representing a 1/400th Interest in a Share of 6.875% Perpetual Non-Cumulative Preferred Stock, Series A

AUB.PRA

New

York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth

company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange

Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use

the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section

13(a) of the Exchange Act.

Item 1.01 Entry into a Material Definitive Agreement.

On July 27, 2026, Atlantic Union Bankshares Corporation

(the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Keefe, Bruyette &

Woods, Inc. and Piper Sandler & Co., as representatives to the underwriters listed in Schedule I thereto, with respect to the offer

and sale of $250 million aggregate principal amount of its 6.25% Fixed-to-Floating Rate Subordinated Notes due 2036 (the “Notes”)

at a public offering price equal to 100.00% of the aggregate principal amount of the Notes. The offering of the Notes is expected to close

on or about July 30, 2026, subject to customary closing conditions.

The Underwriting Agreement contains customary

representations, warranties and covenants and includes the terms and conditions for the sale of the Notes, indemnification and contribution

obligations and other terms and conditions customary in agreements of this type. The foregoing description is qualified in its entirety

by reference to the Underwriting Agreement, a copy of which is attached hereto as Exhibit 1.1 and incorporated herein by reference.

The Company intends to

use the net proceeds from this offering to repay $168.0 million aggregate principal amount of its outstanding 4.25% Fixed-to-Floating

Rate Subordinated Notes due 2029 (the “2029 Notes”), plus accrued interest, and for general corporate purposes, including

providing capital to Atlantic Union Bank to support its growth. A conditional notice of redemption was delivered to the holders of the

2029 Notes with respect to the redemption of all of the outstanding principal amount of the 2029 Notes. The redemption of the Company’s

2029 Notes is contingent on the completion of the offering of the Notes and the amount of proceeds resulting from the offering thereof.

The Notes are offered pursuant to the Company’s

Registration Statement on Form S-3ASR (File No. 333-281290) (including base prospectus) under the Securities Act of 1933, as amended,

which was filed with the Securities and Exchange Commission (the “SEC”) and automatically became effective on August 6, 2024,

as supplemented by a preliminary prospectus supplement filed with the SEC and a final prospectus supplement to be filed with the SEC.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description of Exhibit

1.1

Underwriting Agreement, dated July 27, 2026, between Atlantic Union Bankshares Corporation, Keefe, Bruyette & Woods, Inc. and Piper Sandler & Co.

104

Cover Page Interactive Data File – the cover page iXBRL tags are embedded within the Inline XBRL document

Forward-Looking Statements

This report and certain other communications by

the Company contain statements that constitute “forward-looking statements” within the meaning of, and subject to the protections

of, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements, including but not

limited to those regarding the offering and the use of proceeds therefrom, are based on currently available information and are subject

to various risks and uncertainties that could cause actual results to differ materially from the Company’s present expectations.

These risks and uncertainties include, but are not limited to, market conditions affecting the offering. Undue reliance should not be

placed on such forward-looking statements, as such statements speak only as of the date on which they are made and the Company undertakes

no obligation to update such statements. Additional information regarding these and other risks is contained in the Company’s filings

with the SEC.

SIGNATURES

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ATLANTIC UNION BANKSHARES CORPORATION

Date: July 27, 2026

By:

/s/ Alexander D. Dodd

Alexander D. Dodd

Executive Vice President and

Chief Financial Officer

EX-1.1 — EXHIBIT 1.1

EX-1.1

Filename: tm2621299d2_ex1-1.htm · Sequence: 2

Exhibit 1.1

$250,000,000.00

6.25% Fixed-to-Floating Rate Subordinated

Notes due August 1, 2036

Atlantic Union Bankshares Corporation

UNDERWRITING AGREEMENT

July 27, 2026

KEEFE, BRUYETTE & WOODS, INC.

PIPER SANDLER & CO.

c/o KEEFE, BRUYETTE & WOODS, INC.

The Equitable Building

787 Seventh Avenue, 4th Floor

New York, NY 10019

c/o PIPER SANDLER & CO.

1251 Avenue of the Americas, 6th Floor

New York, New York 10020

As Representatives of the Underwriters listed in Schedule I

hereto.

Ladies and Gentlemen:

Atlantic Union Bankshares Corporation, a Virginia

corporation (the “Company”), confirms its agreement (the “Agreement”) with Keefe, Bruyette &

Woods, Inc. (“KBW”) and Piper Sandler & Co. (“PSC”) and each of the other Underwriters named

in Schedule I hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted

as provided pursuant to SECTION 11 hereof), for whom KBW and PSC are acting as representatives (in such capacity, the “Representatives”),

with respect to the issue and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of $250,000,000.00

aggregate principal amount of its 6.25% Fixed-to-Floating Rate Subordinated Notes due August 1, 2036 (the “Securities”).

The Securities will be issued in book-entry only form to Cede & Co. as nominee of The Depository Trust Company (“DTC”)

pursuant to the Letter of Representations, to be dated as of the Closing Time (as defined in SECTION 2 hereof), between the Company

and DTC.

The Securities will be issued pursuant to the Subordinated

Indenture between the Company and U.S. Bank Trust Company, National Association (as successor to U.S. Bank National Association), as Trustee

(the “Trustee”), dated as of December 5, 2016, as supplemented by a supplemental indenture thereto to be dated

as of July 30, 2026, between the Company and the Trustee (collectively, the “Indenture”). The Indenture and this Agreement

are hereinafter referred to collectively as the “Operative Documents.”

The Company has prepared and filed with the United

States Securities and Exchange Commission (the “Commission”) an “automatic shelf registration statement,”

as defined under Rule 405 (“Rule 405”) of the rules and regulations of the Commission under the Securities

Act of 1933 (the “Securities Act,” and such rules and regulations promulgated thereunder being referred to as the “Securities

Act Regulations”), on Form S-3 (File No. 333-281290), which includes the form of prospectus covering the public offering

and sale of certain securities of the Company, including the Securities, under the Securities Act and which automatic shelf registration

statement became effective upon filing with the Commission under Rule 462(e) under the Securities Act Regulations. Such registration

statement, as of any time, means such registration statement as amended by any post-effective amendment thereto at such time, including

the exhibits and any schedules thereto at such time, and including the documents incorporated or deemed to be incorporated by reference

therein at such time pursuant to Item 12 of Form S-3 and any post-effective amendment, prospectus supplement or other documents

otherwise deemed to be a part thereof as of such time pursuant to Rule 430B under the Securities Act Regulations (“Rule 430B”),

and is referred to herein as the “Registration Statement.” The form of prospectus appearing in the Registration Statement

at the time of its initial effectiveness and including the documents incorporated by reference therein is hereinafter called the “Base

Prospectus.” Each preliminary prospectus supplement and the Base Prospectus used in connection with the offering of the Securities,

in the form of which has been or will be filed with the Commission pursuant to Rule 424(b) under the Securities Act Regulations (“Rule 424(b)”),

including the documents incorporated or deemed to be incorporated by reference therein pursuant to Item 12 of Form S-3 immediately

prior to the time of its first use, are collectively referred to herein as a “preliminary prospectus.” Promptly after execution

and delivery of this Agreement, the Company will prepare and file with the Commission a final prospectus supplement relating to the Securities

in accordance with the provisions of Rule 424(b). The final prospectus supplement and the Base Prospectus, in the form first furnished

to the Underwriters for use in connection with the offering and sale of the Securities, including the documents incorporated or deemed

to be incorporated by reference therein pursuant to Item 12 of Form S-3 immediately prior to the Applicable Time (as defined

below), are collectively referred to herein as the “Prospectus.” For purposes of this Agreement, all references to

the Registration Statement, the Base Prospectus, any preliminary prospectus, the Prospectus or any amendment or supplement to any of the

foregoing shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval

system (or any successor system) (“EDGAR”).

As used in this Agreement:

“Applicable Time” means 2:36

p.m., New York City time, on July 27, 2026, or such other time as agreed by the Company and the Representatives.

“Issuer Free Writing Prospectus”

means any “issuer free writing prospectus,” as defined in Rule 433 under the Securities Act Regulations (“Rule 433”),

including, without limitation, any “free writing prospectus” (as defined in Rule 405) relating to the Securities that

is (i) required to be filed with the Commission by the Company, (ii) a “road show that is a written communication”

within the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission, or (iii) exempt from filing

with the Commission pursuant to Rule 433(d)(5)(i) because it contains a description of the Securities or of the offering thereof

that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required

to be filed, in the form retained in the Company’s records pursuant to Rule 433(g).

“Issuer General Use Free Writing Prospectus”

means any Issuer Free Writing Prospectus that is intended for general distribution to investors, as evidenced by its being specified in

Schedule II hereto.

“Statutory Prospectus” as of

any time means the applicable prospectus relating to the Securities that is, immediately prior to that time, either included in the Registration

Statement or deemed to be a part thereof, including any document incorporated therein by reference immediately prior to that time and

any preliminary prospectus deemed to be a part thereof.

All references in this Agreement to financial statements

and schedules and other information which is “contained,” “included” or “stated” (or other references

of like import) in the Registration Statement, the Disclosure Package, any preliminary prospectus or the Prospectus shall be deemed to

include all such financial statements and schedules and other information incorporated or deemed to be incorporated by reference in the

Registration Statement, the Disclosure Package, any preliminary prospectus or the Prospectus, as the case may be, prior to the Applicable

Time; and all references in this Agreement to amendments or supplements to the Registration Statement, the Disclosure Package, any preliminary

prospectus or the Prospectus shall be deemed to include the filing of any document under the Securities Exchange Act of 1934 (the “Exchange

Act”), and the rules and regulations promulgated thereunder (the “Exchange Act Regulations”) incorporated

or deemed to be incorporated by reference in the Registration Statement, the Disclosure Package, such preliminary prospectus or the Prospectus,

as the case may be, at or after the Applicable Time.

The Company confirms as follows with the Representatives

and the several other Underwriters.

Section 1.

Representations and Warranties.

The Company represents and warrants to each Underwriter

at the Applicable Time and at the Closing Time (as defined below), and agrees with each Underwriter, as follows:

(a)

Well-Known Seasoned Issuer. (i) At the original effectiveness of the Registration Statement, (ii) at the time

of the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the Securities Act (whether such amendment

was by post-effective amendment, incorporated report filed pursuant to Section 13 or 15(d) of the Exchange Act or form of prospectus),

(iii) at the time the Company or any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under

the Securities Act Regulations) made any offer relating to the Securities in reliance on the exemption of Rule 163 under the Securities

Act Regulations (“Rule 163”) and (iv) at the Applicable Time, the Company was and is a “well-known

seasoned issuer,” as defined in Rule 405, including not having been and not being an “ineligible issuer” (as defined

in Rule 405). At the earliest time that the Company or another offering participant made a bona fide offer (within the meaning

of Rule 164(h)(2) under the Securities Act Regulations) of the Securities, the Company was not nor is an “ineligible issuer”

(as defined in Rule 405). The Company has paid the registration fee for this offering pursuant to Rule 456(b)(1)(i) under the

Securities Act or will pay such fee within the time period required by such rule (without giving effect to the proviso therein) and otherwise

in accordance with Rules 456(b) and 457(r) under the Securities Act Regulations, and in any event prior to the Closing Time.

(b)

Compliance of the Registration Statement, the Prospectus and Incorporated Documents. At the time the Registration Statement

and any post-effective amendments thereto were filed with the Commission and at the time hereof, the Company met the requirements for

use of Form S-3 under the Securities Act. The Registration Statement is an automatic shelf registration statement under Rule 405,

and the offer and sale of the Securities is registered by the Company on such automatic shelf registration statement. The Registration

Statement and any post-effective amendment thereto became effective automatically upon the filing thereof with the Commission under the

Securities Act and the initial effective date of the Registration Statement is not more than three years before the date of this Agreement.

No stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has been issued under

the Securities Act, no notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment

thereto pursuant to Rule 401(g)(2) under the Securities Act Regulations (“Rule 401(g)(2)”) has been received

by the Company, no order preventing or suspending the use of any preliminary prospectus or the Prospectus or any amendment or supplement

thereto has been issued and no proceedings for any of those purposes have been instituted or are pending or, to the Company’s knowledge,

contemplated. The Company has complied with each request (if any) from the Commission for additional information. The Company meets the

requirements under the Securities Act specified in the Financial Industry Regulatory Authority, Inc. (“FINRA”) Conduct

Rule 5110(b)(7)(C)(i).

Each of the Registration Statement and any post-effective

amendment thereto, at the time of its effectiveness, at the Closing Time and as of each deemed effective date with respect to the Underwriters

pursuant to paragraph (f)(2) of Rule 430B, complied, in all material respects, with the requirements of the Securities Act,

the Securities Act Regulations and the Trust Indenture Act of 1939, as amended (the “TIA”), and the rules and regulations

of the Commission under the TIA (the “TIA Regulations”). Each preliminary prospectus, the Prospectus and any amendment

or supplement thereto, at the time each was filed with the Commission, complied, in all material respects, with the requirements of the

Securities Act, the Securities Act Regulations, the TIA and the TIA Regulations, and are identical to the electronically transmitted copies

thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.

The documents incorporated or deemed to be incorporated

by reference in the Registration Statement, the Disclosure Package and the Prospectus, when they became effective or at the time they

were or hereafter are filed with the Commission, complied and will comply, in all material respects, with the requirements of the Exchange

Act and the Exchange Act Regulations.

(c)

Accurate Disclosure. Neither the Registration Statement nor any post-effective amendment thereto, at its effective time

or at the Closing Time (as defined below), contained, contains or will contain an untrue statement of a material fact or omitted, omits

or will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. At the

Applicable Time, any Issuer General Use Free Writing Prospectus and the Statutory Prospectus, when considered together (collectively,

as of the Applicable Time, the “Disclosure Package”), did not, does not and will not include an untrue statement of

a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances

under which they were made, not misleading. Neither the Prospectus nor any amendment or supplement thereto, as of its issue date or at

the Closing Time, included, includes or will include an untrue statement of a material fact or omit to state a material fact necessary

in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The documents incorporated

or deemed to be incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, at the time the Registration

Statement became effective or when such incorporated documents were filed with the Commission, as the case may be, when read together

with the other information in the Registration Statement, the Disclosure Package or the Prospectus, as the case may be, did not, does

not and will not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary

to make the statements therein not misleading. There are no statutes, regulations, documents or contracts of a character required to be

described in the Registration Statement, the Disclosure Package and the Prospectus, or to be filed as an exhibit to the Registration Statement,

which are not described or filed as required. There are no business relationships or related person transactions involving the Company

or any subsidiary or any other person required to be described in the Registration Statement, the Disclosure Package and the Prospectus

that have not been described as required.

The representations and warranties in this subsection

shall not apply to statements in or omissions from the Registration Statement or any amendment thereto or the Disclosure Package or the

Prospectus or any amendment or supplement thereto made in reliance upon and in conformity with written information furnished to the Company

by any Underwriter through the Representatives expressly for use therein. For purposes of this Agreement, the only information so furnished

shall consist of the following: the discount information appearing in the Prospectus under the heading “Underwriting (Conflict of

Interest)” and the information relating to stabilizing transactions, syndicate covering transactions and penalty bids in the first

paragraph under the caption “Underwriting—Price Stabilization, Short Positions” in each of the preliminary prospectus

and the Prospectus (collectively, the “Underwriter Information”).

(d)

Issuer Free Writing Prospectuses. No Issuer Free Writing Prospectus conflicts or will conflict with the information contained

in the Registration Statement, any preliminary prospectus or the Prospectus, including any document incorporated by reference therein,

that has not been superseded or modified.

(e)

Independent Accountants. Ernst & Young LLP (“EY”), the accounting firm that certified the financial

statements and supporting schedules of the Company that are included in the Registration Statement and the Prospectus, is (i) an

independent registered public accounting firm with respect to the Company as required by the Securities Act, the Securities Act Regulations,

the Exchange Act, the Exchange Act Regulations and the Public Company Accounting Oversight Board (the “PCAOB”), which

has not had its registration superseded or revoked and which has not requested that such registration be withdrawn, and (ii) with

respect to the Company, is not and has not been in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002

(the “Sarbanes-Oxley Act”) and the rules and regulations of the Commission during any time period for which EY has

served as the Company’s independent registered public accounting firm.

(f)

Financial Statements; Non-GAAP Financial Measures. The financial statements of the Company and its consolidated subsidiaries

included in the Registration Statement, the Disclosure Package and the Prospectus, together with the related schedules and notes, comply

with the requirements of the Securities Act and present fairly, in all material respects, the financial position of the Company and its

consolidated subsidiaries. The financial statements of the Company and its consolidated subsidiaries, at the dates indicated, have been

prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) applied on a consistent basis throughout

the periods involved. The supporting schedules, if any, present fairly, in all material respects, in accordance with GAAP the information

required to be stated therein. To the extent applicable, all disclosures contained in the Registration Statement, the Disclosure Package

or the Prospectus, if any, regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of

the Commission) comply with Regulation G under the Exchange Act and Item 10(e) of Regulation S-K under the Securities Act,

in all material respects.

(g)

Interactive Data. The interactive data in Inline eXtensible Business Reporting Language incorporated by reference in the

Registration Statement, the Disclosure Package and the Prospectus fairly presents the information called for in all material respects

and has been prepared in accordance with the requirements of the Securities Act and the Commission’s rules and guidelines applicable

thereto.

(h)

No Material Adverse Change in Business. Since the respective dates as of which information is given in the Registration

Statement, the Disclosure Package and the Prospectus, except as otherwise stated therein, (i) there has been no material adverse

effect, or any development that could be expected to result in a material adverse effect, (A) on the general affairs, condition (financial

or otherwise), business, properties, prospects, management, financial position, shareholders’ equity, assets, liabilities or results

of operations of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business

or (B) in the ability of the Company to perform its obligations under, and to consummate the transactions contemplated by, this Agreement

(each of (A) and (B) a “Material Adverse Effect”), (ii) there has not been any change in the capital stock or

long-term debt or any material changes in short-term debt of the Company or any of the subsidiaries, (iii) there have been no transactions

entered into by, and no obligations or liabilities, contingent or otherwise, incurred by the Company or any of the subsidiaries, whether

or not in the ordinary course of business, which are material to the Company and the subsidiaries, considered as one enterprise, (iv) the

Company has not purchased any of its outstanding capital stock and there has been no dividend or distribution of any kind declared, paid

or made by the Company on any class of its capital stock and (v) there has been no material loss or interference with the Company’s

business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental

action, order or decree.

(i)

Good Standing of the Company. The Company has been duly organized and is validly existing as a corporation in good standing

under the laws of the Commonwealth of Virginia and has corporate power and authority to own, lease and operate its properties and to conduct

its business as described in the Registration Statement, the Disclosure Package and the Prospectus and to enter into and perform its obligations

under this Agreement; and the Company is duly qualified as a foreign corporation to transact business and is in good standing in each

other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of

business, except where the failure to so qualify or to be in good standing could not result in a Material Adverse Effect.

(j)

Good Standing of Subsidiaries. Atlantic Union Bank (the “Bank”) is a bank chartered under the laws of

the Commonwealth of Virginia, and the charter of the Bank is in full force and effect. The Bank, AUB Investments, Inc., Atlantic

Union Equipment Finance, Inc. and Atlantic Union Capital Markets, Inc. are the only “significant subsidiaries” of the Company

(as such term is defined in Rule 1-02 of Regulation S-X) (each, a “Significant Subsidiary” and, collectively,

the “Significant Subsidiaries”). Each Significant Subsidiary has been duly organized and is validly existing as a corporation

or other organization in good standing under the laws of the jurisdiction of its incorporation, formation or organization, has the requisite

corporate or organizational power and authority to own, lease and operate its properties and to conduct its business as described in the

Registration Statement, the Disclosure Package and the Prospectus and is duly qualified as a foreign corporation or other business entity

to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership

or leasing of property or the conduct of business, except where the failure to so qualify or to be in good standing could not result in

a Material Adverse Effect. All of the issued and outstanding shares of capital stock or other equity interests of each subsidiary of the

Company have been duly authorized and validly issued and are fully paid and non-assessable, as applicable, and are owned by the Company,

directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equitable right;

none of the outstanding shares of capital stock or other equity interests of any subsidiary of the Company was issued in violation of

the preemptive or similar rights of any securityholder of such subsidiary arising by operation of law, or under the articles of incorporation,

bylaws or other organizational documents of the Company or any subsidiary or under any agreement to which the Company or any subsidiary

is a party.

(k)

Capitalization. The authorized, issued and outstanding capital stock of the Company is as set forth in the Registration

Statement, the Disclosure Package and the Prospectus (except for subsequent issuances, if any, pursuant to reservations, agreements or

employee benefit plans referred to in the Registration Statement, the Disclosure Package and the Prospectus or pursuant to the exercise

of convertible securities or options referred to in the Registration Statement, the Disclosure Package and the Prospectus). All issued

and outstanding shares of Common Stock have been duly authorized and validly issued and are fully paid and non-assessable; none of the

outstanding shares of Common Stock were issued in violation of the preemptive rights, rights of first refusal or other similar rights

of any securityholder of the Company arising by operation of law, or under the articles of incorporation, bylaws or other organizational

documents of the Company or any subsidiary or under any agreement to which the Company or any subsidiary is a party.

(l)

Authorization of Agreement. The Company has full right, power and authority to execute and deliver this Agreement and to

perform its obligations hereunder; and all action required to be taken for the due and proper authorization, execution and delivery by

it of this Agreement and the consummation by it of the transactions contemplated hereby has been duly and validly taken. This Agreement

has been duly authorized, executed and delivered by the Company.

(m)

Authorization of Indenture. The Indenture has been duly authorized by the Company and, when executed and delivered by the

Company, the Indenture will constitute a valid, legal and binding agreement of the Company, enforceable against the Company in accordance

with its terms, except to the extent that enforceability may be limited by (i) bankruptcy, insolvency, reorganization, moratorium,

fraudulent conveyance or other similar laws now or hereafter in effect relating to creditors’ rights generally, (ii) general

principles of equity (regardless of whether enforceability is considered in a proceeding at law or in equity) and (iii) with respect

to the rights to indemnity or contribution, including, but not limited to, indemnification and contribution provisions set forth in this

Agreement, federal or state securities law or the public policy underlying such laws (collectively, the “Enforceability Exceptions”).

(n)

Authorization of Securities. The Securities have been duly authorized by the Company and, at the Closing Time, will have

been duly executed by the Company and, when authenticated in the manner provided for in the Indenture and delivered by the Company against

payment therefor as described in the Prospectus or as contemplated in the Indenture, will constitute valid, legal and binding obligations

of the Company, enforceable against the Company in accordance with their terms, except to the extent that enforceability may be limited

by the Enforceability Exceptions; the Securities will be in the form contemplated by, and will be entitled to the benefits of, the Indenture.

(o)

Descriptions of Securities. The Securities will conform, in all material respects, to all statements relating thereto contained

in the Registration Statement, the Prospectus and the Disclosure Package.

(p)

Qualification under the TIA. The Indenture has been duly qualified with respect to the Securities under the TIA.

(q)

Registration Rights. There are no contracts, agreements or understandings between the Company and any person granting such

person registration rights or other similar rights to have any securities registered for resale pursuant to the Registration Statement

or otherwise registered by the Company under the Securities Act.

(r)

Absence of Defaults and Conflicts. The Company is not in violation of its Amended and Restated Articles of Incorporation,

as further amended (the “Charter”), or Amended and Restated Bylaws (the “Bylaws”); no subsidiary

of the Company is in violation of its charter, bylaws or other organizational documents and neither the Company nor any of its subsidiaries

is in default in the performance or observance of any obligation, agreement, covenant or condition contained in any contract, indenture,

mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Company or any of its subsidiaries

is a party or by which it or any of them may be bound, or to which any of the property or assets of the Company or any subsidiary is subject

(collectively, “Agreements and Instruments”), or in violation of any law or statute or any judgment, order, rule or

regulation of any court or arbitrator or governmental or regulatory authority, except in all cases for such violations or defaults that

would not reasonably be expected to, individually or in the aggregate, result in a Material Adverse Effect. The execution, delivery and

performance of the Operative Documents and the Securities by the Company, the issuance, sale and delivery of the Securities, the consummation

of the transactions contemplated by the Operative Documents and the Securities and in the Registration Statement, the Prospectus and the

Disclosure Package (including the use of proceeds from the sale of the Securities), and compliance by the Company with the terms of the

Operative Documents and the Securities have been duly authorized by all necessary corporate action and do not and will not, whether with

or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or default or Repayment Event (as

defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company

or any subsidiary pursuant to, the Agreements and Instruments (except for such conflicts, breaches, defaults, Repayment Events or liens,

charges or encumbrances that would not reasonably be expected to, individually or in the aggregate, result in a Material Adverse Effect);

nor will such action result in any violation of the provisions of the Charter or Bylaws of the Company or the charter, bylaws or other

organizational document of any subsidiary of the Company; nor will such action result in any violation of any applicable law, statute,

rule, regulation, judgment, order, writ or decree of any government, government instrumentality or court, domestic or foreign, having

jurisdiction over the Company or any subsidiary or any of their assets, properties or operations (except for such violations that would

not reasonably be expected to, individually or in the aggregate, result in a Material Adverse Effect). As used herein, a “Repayment

Event” means any event or condition which gives the holder of any note, debenture or other evidence of indebtedness (or any

person acting on such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such

indebtedness by the Company or any subsidiary.

(s)

Absence of Labor Dispute. No labor dispute with the employees of the Company or any subsidiary exists or, to the knowledge

of the Company, is imminent. The Company is not aware of any existing or imminent labor disturbance by the employees of any of its or

any subsidiary’s principal suppliers, manufacturers, customers or contractors, which, in either case, would reasonably be expected

to, individually or in the aggregate, result in a Material Adverse Effect.

(t)

Absence of Proceedings. There is no action, suit, proceeding, inquiry or investigation before or brought by any court or

governmental agency or body, domestic or foreign, now pending, or, to the knowledge of the Company, threatened, against or affecting the

Company or any subsidiary, which is required to be disclosed in the Registration Statement (other than as disclosed therein), or which,

if determined adversely to the Company or any subsidiary, individually or in the aggregate, would reasonably be expected to result in

a Material Adverse Effect, or which would materially and adversely affect the consummation of the transactions contemplated by the Operative

Documents and the Securities or the performance by the Company of its obligations hereunder and thereunder. There are no legal or governmental

proceedings to which the Company or any subsidiary is a party or of which any of their respective property or assets is the subject, including

ordinary routine litigation incidental to the business, which would, in the aggregate, reasonably be expected to have a Material Adverse

Effect.

(u)

Bank Holding Company Act. The Company has been duly registered as, and meets in all material respects the applicable requirements

for qualification as, a bank holding company and has elected to be treated as a financial holding company under the applicable provisions

of the Bank Holding Company Act of 1956, as amended. The activities of the subsidiaries are permitted for subsidiaries of a financial

holding company under applicable law and the rules and regulations of the Federal Reserve set forth in Title 12 of the Code of Federal

Regulations.

(v)

Compliance with Bank Regulatory Authorities. The Company and each of its subsidiaries are in compliance in all material

respects with all applicable laws, rules and regulations (including, without limitation, all applicable regulations and orders) of, or

agreements with, the Board of Governors of the Federal Reserve System, the Federal Deposit Insurance Corporation (the “FDIC”),

and the Bureau of Financial Institutions of the Virginia State Corporation Commission (the “Bureau”), as applicable

(collectively, the “Bank Regulatory Authorities”), the Equal Credit Opportunity Act, the Fair Housing Act, the Truth

in Lending Act, the Community Reinvestment Act (the “CRA”), the Home Mortgage Disclosure Act, the Bank Secrecy Act

and Title III of the USA PATRIOT Act (or otherwise known as “Uniting and Strengthening America by Providing Appropriate

Tools Required to Intercept and Obstruct Terrorism Act of 2001”), to the extent such laws or regulations apply to the Company

or the Bank, as applicable. The Company and the Bank have no knowledge of any facts and circumstances, and have no reason to believe that

any facts or circumstances exist, that could cause the Bank (A) to be deemed not to be in satisfactory compliance with the CRA and

the regulations promulgated thereunder or to be assigned a CRA rating by federal or state banking regulators of lower than “satisfactory,”

or (B) to be deemed to be operating in violation, in any material respect, of the Bank Secrecy Act of 1970 (or otherwise known as

the “Currency and Foreign Transactions Reporting Act”), the USA PATRIOT Act or any order issued with respect to the

Anti-Money Laundering Laws (as defined below). The Bank is “well capitalized” under the FDIC’s regulatory framework

for prompt corrective action. The Bank has been duly chartered, is validly existing under the laws of the Commonwealth of Virginia and

holds the requisite authority to do business as a state-chartered bank with banking powers under the laws of the Commonwealth of Virginia.

The Bank is the only depository institution subsidiary of the Company and the Bank is a member in good standing of the Federal Home Loan

Bank System. The activities of the Bank are permitted under the laws and regulations of the Commonwealth of Virginia. Since December 31,

2022, each of the Company, the Bank and each of their subsidiaries have filed all material reports, registrations and statements, together

with any required amendments thereto, that each was required to file with the Federal Reserve, the FDIC, the Bureau and any other applicable

federal or state banking authorities. All such reports and statements filed with any such regulatory body or authority are collectively

referred to herein as the “Company Reports.” As of their respective dates, the Company Reports complied as to form

in all material respects with all applicable rules and regulations promulgated by the Federal Reserve, the FDIC, the Bureau and any other

applicable federal or state banking authorities, as the case may be.

(w)

Regulatory Enforcement Matters. None of the Company, the Bank or any of their respective subsidiaries is a party or subject

to any formal or informal agreement, memorandum of understanding, consent decree, directive, cease-and-desist order, order of prohibition

or suspension, written commitment, supervisory agreement or other written statement as described under 12 U.S.C. § 1818(u) with,

or order issued by, or has adopted any board resolutions at the request of, the Federal Reserve, the FDIC, the Bureau or any other bank

regulatory authority that restricts materially the conduct of its business, or in any manner relates to its capital adequacy, its credit

policies or its management, nor have any of them been advised by any Bank Regulatory Authority that it is contemplating issuing or requesting

(or is considering the appropriateness of issuing or requesting) any such order, decree, agreement, memorandum of understanding, extraordinary

supervisory letter, commitment letter or similar submission, where such order, decree, agreement, memorandum of understanding, extraordinary

supervisory letter, commitment letter or similar submission would reasonably be expected to result in a Material Adverse Effect. There

is no unresolved violation, criticism or exception by any Bank Regulatory Authority with respect to any examination of the Company, the

Bank or any of the Company’s other subsidiaries, which would reasonably be expected to result in a Material Adverse Effect.

(x)

Accuracy of Exhibits. There are no contracts or documents which are required to be described in the Registration Statement,

the Disclosure Package, the Prospectus or the documents incorporated by reference therein or to be filed as exhibits thereto which have

not been so described and filed as required.

(y)

Absence of Further Requirements. No filing with, or authorization, approval, consent, license, order, registration, qualification

or decree of, any court or governmental agency or body is necessary or required for the performance by the Company of its obligations

under the Operative Documents or the Securities, or the consummation of the transactions contemplated thereunder, except such as have

been already obtained or as may be required under the Securities Act, the Securities Act Regulations, the Exchange Act, the Exchange Act

Regulations, the rules of Nasdaq, the securities laws of any state or non-U.S. jurisdiction or the rules of FINRA. All of the information

provided to the Underwriters or to counsel for the Underwriters by the Company, its counsel, its officers and directors and the holders

of any securities (debt or equity) or options to acquire any securities of the Company in connection with the offering of the Securities

and for the purpose of compliance with the rules of FINRA is true, complete and correct in all material respects, and any letters, filings

or other supplemental information provided to FINRA pursuant to FINRA Rules or National Association of Securities Dealers Conduct Rules

are true, complete and correct in all material respects.

(z)

Possession of Licenses and Permits. The Company and its subsidiaries possess such permits, licenses, approvals, registrations,

memberships, consents and other authorizations (collectively, “Governmental Licenses”) issued by the appropriate federal,

state, local or foreign regulatory agencies or bodies necessary to conduct the business now operated by them; the Company and its subsidiaries

are in compliance with the terms and conditions of all such Governmental Licenses, except where the failure to so comply could not, individually

or in the aggregate, have a Material Adverse Effect and no event has occurred that allows, or after notice or lapse of time would allow,

revocation or termination of any such Governmental License or result in any other material impairment of the rights of any such Governmental

License; all of the Governmental Licenses are valid and in full force and effect, except where the invalidity of such Governmental License

or the failure of such Governmental License to be in full force and effect would not reasonably be expected to have a Material Adverse

Effect; and neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or modification

of any such Governmental Licenses which, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding,

would reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of its subsidiaries has failed to file with

applicable regulatory authorities any material statement, report, information or form required by any applicable law, regulation or order,

except where such failure to be so in compliance would not reasonably be expected to, individually or in the aggregate, have a Material

Adverse Effect, all such filings were in material compliance with applicable laws when filed and no material deficiencies have been asserted

by any regulatory commission, agency or authority with respect to any such filings or submissions.

(aa)

Conduct of Business. Except as otherwise disclosed in the Registration Statement, the Disclosure Package and the Prospectus,

each of the Company and the Bank is conducting its business in compliance with all laws, rules, regulations, decisions, directives and

orders, and all regulations and orders of, or agreements with, any court or governmental agency or body applicable to it, except where

failure to so comply would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect.

(bb)

Title to Property. The Company and its subsidiaries have good and marketable title in fee simple to all real property owned

by the Company and its subsidiaries and good title to all other properties owned by them, in each case, free and clear of all mortgages,

pledges, liens, security interests, claims, restrictions or encumbrances of any kind except such as (i) are described in the Registration

Statement, the Disclosure Package and the Prospectus or (ii) do not materially affect the value of such property and do not interfere

with the use made and proposed to be made of such property by the Company or any subsidiary. All of the leases and subleases material

to the business of the Company and its subsidiaries, considered as one enterprise, and under which the Company or any of its subsidiaries

holds properties described in the Registration Statement, the Disclosure Package and the Prospectus, are in full force and effect and

are held under valid, subsisting and enforceable leases, and neither the Company nor any subsidiary has any notice of any material claim

of any sort that has been asserted by anyone adverse to the rights of the Company or any subsidiary under any of the leases or subleases

mentioned above, or affecting or questioning the rights of the Company or such subsidiary to the continued possession of the leased or

subleased premises under any such lease or sublease.

(cc)

Possession of Intellectual Property. The Company and its subsidiaries own or possess, or can acquire on reasonable terms,

adequate patents, patent rights, licenses, inventions, copyrights, know-how (including trade secrets and other unpatented and/or unpatentable

proprietary or confidential information, systems or procedures and excluding generally commercially available “off the shelf”

software programs licensed pursuant to shrink wrap or “click and accept” licenses), systems, technology, trademarks, service

marks, trade names or other intellectual property (collectively, “Intellectual Property”) reasonably necessary to carry

on the business now operated by them, and neither the Company nor any of its subsidiaries has received any notice or is otherwise aware

of any infringement of or conflict with asserted rights of others with respect to any Intellectual Property or of any facts or circumstances

which would reasonably be expected to render any Intellectual Property invalid or inadequate to protect the interest of the Company or

any of its subsidiaries therein, except where the failure to possess such Intellectual Property or where such infringement or conflict

(if the subject of an unfavorable ruling or finding) or invalidity or inadequacy, individually or in the aggregate, would not result in

a Material Adverse Effect.

(dd)

Environmental Laws. Except as would not, individually or in the aggregate, reasonably be expected to result in a Material

Adverse Effect, (i) neither the Company nor any of its subsidiaries is in violation of any federal, state, local or foreign statute,

law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including

any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment

(including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without

limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances,

hazardous substances, petroleum or petroleum products, asbestos-containing materials or mold (collectively, “Hazardous Materials”)

or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively,

“Environmental Laws”), (ii) the Company and its subsidiaries have all permits, authorizations and approvals required

under any applicable Environmental Laws and are each in compliance with their requirements, (iii) there are no pending or, to the

Company’s knowledge, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices

of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any of its subsidiaries

and (iv) to the Company’s knowledge, there are no events or circumstances that could result in forming the basis of an order

for clean-up or remediation, or an action, suit or proceeding by any private party or governmental body or agency, against or affecting

the Company or any of its subsidiaries relating to Hazardous Materials or any Environmental Laws.

(ee)

ERISA. Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act

of 1974, as amended, and the regulations and published interpretations thereunder (collectively, “ERISA”), that is

maintained, administered or contributed to by the Company or any subsidiary or any trade or business, whether or not incorporated, which

would be treated as a single employer with the Company or the subsidiaries pursuant to Section 414 of the Internal Revenue Code of

1986, as amended (the “Code”) or 4001(b) of ERISA (an “ERISA Affiliate”) for employees or former

employees of the Company and its affiliates, or pursuant to which the Company, a subsidiary, or one of their ERISA Affiliates has any

liability (each, a “Plan”) has been maintained in material compliance with its terms and the requirements of any applicable

statutes, orders, rules and regulations, including, but not limited to, ERISA and the Code, and the Company and its subsidiaries and ERISA

Affiliates have fulfilled their obligations with respect to each Plan except where the failure to so comply would not, individually or

in the aggregate, reasonably be expected to result in a Material Adverse Effect. To the knowledge of the Company, no “prohibited

transaction,” within the meaning of Section 406 of ERISA or Section 4975 of the Code has occurred or is reasonably expected

to occur with respect to any such Plan excluding transactions effected pursuant to a statutory, class or administrative exemption. No

“reportable event” (as defined under ERISA) has occurred or is reasonably expected to occur with respect to any “employee

benefit plan” established or maintained by the Company or its subsidiaries that is subject to Title IV of ERISA, and no failure

to satisfy the minimum funding standards (within the meaning of Section 412 of the Code or Section 302 of ERISA), has occurred or is reasonably

expected to occur with respect to any Plan, except as would not, individually or in the aggregate, reasonably be expected to result in

a Material Adverse Effect.

Neither the Company, the subsidiaries nor any of

their ERISA Affiliates has incurred or reasonably expects to incur any liability (i) under Title IV of ERISA (other than contributions

to the Plan or any multiemployer plan or premiums to the Pension Benefit Guaranty Corporation, in the ordinary course and without default),

(ii) with respect to the termination of, or withdrawal from, any Plan, or (iii) under Sections 412, 4971, 4975 or 4980B of the

Code (excluding any liability for premiums for health care continuation benefits to which the Company, its subsidiaries, or its ERISA

Affiliates have contractually agreed to pay pursuant to employment, consulting or severance agreements), and (iv) no Plan is, or is reasonably

expected to be, in “at risk status” (within the meaning of Section 303(i) of ERISA) and no “multiemployer plan”

(within the meaning of Section 4001(a)(3) of ERISA is in or expected to be in “endangered status” or “critica; status”

(within the meaning of Sections 304 and 305 of ERISA). except as would not, individually or in the aggregate, reasonably be expected to

result in a Material Adverse Effect. Each Plan that is intended to be qualified under Section 401(a) of the Code is so qualified

and nothing has occurred, whether by action or failure to act, which is reasonably expected to result in the loss of such qualification.

None of the following events has occurred or is reasonably likely to occur: (A) a material increase in the aggregate amount of contributions

required to be made to all Plans by the Company or its ERISA Affiliates in the current fiscal year of the Company and its ERISA Affiliates

compared to the amount of such contributions made in the Company’s and its ERISA Affiliates’ most recently completed fiscal

year; or (B) a material increase in the Company and its subsidiaries’ “accumulated post-retirement benefit obligations”

(within the meaning of Accounting Standards Codification Topic 715-60) compared to the amount of such obligations in the Company and its

subsidiaries’ most recently completed fiscal year,. To the knowledge of the Company, there is no pending audit or investigation

by the Internal Revenue Service, the U.S. Department of Labor, the Pension Benefit Guaranty Corporation or any other governmental agency

or any foreign agency with respect to any Plan.

(ff)

Internal Control Over Financial Reporting. The Company and each of its subsidiaries maintain a system of internal control

over financial reporting (as such term is defined in Rule 13a-15(f) of the Exchange Act Regulations) that complies in all material

respects with the requirements of the Exchange Act and has been designed by the Company’s principal executive officer and principal

financial officer and is sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s

general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in

conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s

general or specific authorization; (iv) the recorded accountability for assets is compared with the existing assets at reasonable

intervals and appropriate action is taken with respect to any differences; and (v) the interactive data in Inline eXtensible Business

Reporting Language included or incorporated by reference in the Registration Statement is accurate and fairly presents the information

called for in all material respects and has been prepared in accordance with the Commission’s rules and guidelines applicable thereto.

Since the end of the Company’s most recent audited fiscal year, (A) there has been no material weakness in the Company’s

internal control over financial reporting (whether or not remediated), (B) there has been no change in the Company’s internal

control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal

control over financial reporting and (C) the Company has not been advised of (1) any significant deficiencies in the design

or operation of internal controls that could adversely affect the ability of the Company or any subsidiary to record, process, summarize

and report financial data, or any material weaknesses in internal controls, or (2) any fraud, whether or not material, that involves

management or other employees who have a significant role in the internal controls of the Company or its subsidiaries.

(gg)

Disclosure Controls and Procedures. The Company and its subsidiaries employ disclosure controls and procedures (as such

term is defined in Rule 13a-15(e) of the Exchange Act Regulations), which (i) are designed to ensure that information required

to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported

within the time periods specified in the Commission’s rules and forms and that material information relating to the Company and

its subsidiaries is made known to the Company’s principal executive officer and principal financial officer by others within the

Company and its subsidiaries to allow timely decisions regarding disclosure, (ii) have been evaluated by management of the Company

for effectiveness as of the end of the Company’s most recent fiscal quarter, and (iii) were then effective in all material

respects to perform the functions for which they were established. Based on the evaluation of the Company’s and each subsidiary’s

disclosure controls and procedures described above, the Company is not aware of (A) any significant deficiency in the design or operation

of internal controls which could adversely affect the Company’s or its subsidiaries’ ability to record, process, summarize

and report financial data or any material weaknesses in internal controls or (B) any fraud, whether or not material, that involves

management or other employees who have a significant role in the Company’s or its subsidiaries’ internal controls. Since the

most recent evaluation of the Company’s disclosure controls and procedures described above, there have been no changes in internal

controls or in other factors that could significantly affect internal controls.

(hh)

Compliance with the Sarbanes-Oxley Act. The Company and its directors and officers, in their capacities as such, are in

compliance in all material respects with all applicable provisions of the Sarbanes-Oxley Act and the rules and regulations promulgated

in connection therewith.

(ii)

Pending Proceedings and Examinations. The Registration Statement is not the subject of a pending proceeding or examination

under Section 8(d) or 8(e) of the Securities Act, and the Company is not the subject of a pending proceeding under Section 8A

of the Securities Act in connection with the offering of the Securities.

(jj)

Payment of Taxes. All United States federal income tax returns of the Company and the subsidiaries required by law to be

filed have been timely filed and all taxes shown by such returns or otherwise assessed, which are due and payable, have been paid, except

assessments that have been or will be promptly contested in good faith and as to which adequate reserves have been provided in the Company’s

financial statements in accordance with GAAP. The Company and the subsidiaries have filed all other tax returns that are required to have

been filed by them pursuant to applicable foreign, state, local or other law, except insofar as the failure to file such returns, individually

or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect, and have paid all taxes due pursuant to

such returns or pursuant to any assessment received by the Company or any subsidiary except for such taxes, if any, as are being contested

in good faith and as to which adequate reserves have been provided. The charges, accruals and reserves on the books of the Company and

the subsidiaries in respect of any income and corporation tax liability for any years not finally determined are adequate to meet any

assessments or reassessments for additional income tax for any years not finally determined. There is no tax deficiency that has been

or would reasonably be expected to be asserted against the Company or any of its subsidiaries or any of their respective properties or

assets.

(kk)

Insurance. The Company and each subsidiary are insured by insurers of recognized financial responsibility against such losses

and risks and in such amounts as are prudent and customary in the businesses in which they are engaged; neither the Company nor any of

its subsidiaries has been refused any insurance coverage sought or applied for; and the Company has no reason to believe that it or any

subsidiary will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from

similar insurers as may be necessary to continue its business at a cost that would not reasonably be expected to have a Material Adverse

Effect. All such insurance is in full force as of the date hereof.

(ll)

Investment Company Act. The Company is not, and immediately following consummation of the transactions contemplated hereby

and the application of the net proceeds as described in the Registration Statement, the Prospectus and the Disclosure Package, the Company

will not be required to register as an “investment company” or an entity controlled by an “investment company,”

in each case within the meaning of Section 3(a) of the Investment Company Act of 1940, as amended (the “Investment Company

Act”), without regard to Section 3(c) of the Investment Company Act.

(mm) Stabilization. Neither the Company nor

any of its subsidiaries, nor any affiliates of the Company or its subsidiaries, has taken, directly, or indirectly, and neither the Company

nor any of the subsidiaries, nor any affiliates of the Company or its subsidiaries, will take, directly or indirectly, any action designed

to cause or result in, or which constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price

of any security of the Company or any “reference security” (as defined in Rule 100 of Regulation M under the Exchange

Act) to facilitate the sale or resale of the Securities or otherwise, and has taken no action which would directly or indirectly violate

Regulation M under the Exchange Act.

(nn)

Foreign Corrupt Practices Act. None of the Company, any of its subsidiaries or, to the knowledge of the Company, any director,

officer, agent or employee of the Company or any of its subsidiaries has: (i) used any corporate funds for any unlawful contribution,

gift, entertainment or other unlawful expense relating to political activity in violation of the Foreign Corrupt Practices Act of 1977,

as amended (the “FCPA”); (ii) made or taken an act in furtherance of an offer, promise or authorization of any

direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated

or is in violation of any provision of the FCPA, or any applicable non-U.S. anti-bribery statute or regulation; or (iv) made, offered,

agreed, requested or taken an act in furtherance of any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful

payment. To the knowledge of the Company, its affiliates have conducted their businesses in compliance with the FCPA and have instituted

and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance

therewith.

(oo)

Anti-Money Laundering Laws. The operations of the Company and its subsidiaries and, to the knowledge of the Company, their

respective affiliates, are and have been conducted at all times in compliance in all material respects with applicable financial recordkeeping

and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, the money laundering statutes of all applicable

jurisdictions and the rules and regulations thereunder issued, administered or enforced by any governmental agency or body (collectively,

the “Anti-Money Laundering Laws”); and no action, suit or proceeding by or before any court, governmental agency or

body involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of

the Company, threatened.

(pp)

OFAC. None of the Company or any of its subsidiaries, nor, to the knowledge of the Company, any officer or director of either

the Company or any of its subsidiaries, any agent, employee, affiliate or person acting on behalf of the Company or any of its subsidiaries,

is or has been (i) engaged in any services (including financial services), transfers of goods, software or technology, or any other

business activity related to (A) any country or territory that is the subject or target of Sanctions, including, without limitation,

the Crimea Region, the so-called Donetsk People’s Republic, the so-called Luhansk People’s Republic, Cuba, Iran, North Korea

and Russia (each, a “Sanctioned Country”), (B) the government of any Sanctioned Country, (C) any person,

entity or organization located in, resident in, formed under the laws of, or owned or controlled by the government of, any Sanctioned

Country, or (D) any person, entity or organization made subject of any sanctions administered or enforced by the United States Government,

including, without limitation, the list of Specially Designated Nationals of the Office of Foreign Assets Control of the U.S. Treasury

Department, or by the United Nations Security Council, the European Union, His Majesty’s Treasury, or other relevant sanctions authority

(collectively, “Sanctions”); (ii) engaged in any transfers of goods, technologies or services (including financial

services) that may assist the governments of Sanctioned Countries or facilitate money laundering or other activities proscribed by United

States laws, rules or regulations; (iii) a person, entity or organization currently the subject of any Sanctions; or (iv) located,

organized or resident in any Sanctioned Country. The Company will not directly or indirectly use the proceeds of the offering, or lend,

contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, (i) to fund

or facilitate any activities or business of or with any person or entity that, at the time of such funding or facilitation, is the subject

or target of Sanctions, (ii) to fund or facilitate any activities or business in any Sanctioned Country or (iii) in any other

manner that will result in a violation by any person participating in the transaction, whether as underwriter, advisor, investor or otherwise,

of Sanctions.

(qq)

No Restrictions on Subsidiaries. Except in each case as otherwise disclosed in the Registration Statement, the Disclosure

Package and the Prospectus, no subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other

instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such

subsidiary’s capital stock, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring

any of such subsidiary’s properties or assets to the Company or any other subsidiary of the Company.

(rr)

Statistical and Market-Related Data. The statistical and market-related data contained in the Registration Statement, the

Disclosure Package and the Prospectus are based on or derived from sources which the Company believes are reliable and accurate.

(ss)

Distribution of Offering Material By the Company. The Company has not distributed and will not distribute, prior to the

later of the Closing Time and the completion of the Underwriters’ distribution of the Securities, any offering material in connection

with the offering and sale of the Securities other than the Registration Statement, the preliminary prospectus contained in the Disclosure

Package, the Prospectus, any Issuer Free Writing Prospectus reviewed and consented to by the Representatives and included in Schedule II

hereto or any electronic road show or other written communications reviewed and consented to by the Representatives and listed on Schedule II

hereto (each, a “Company Additional Written Communication”). Each such Company Additional Written Communication, when

taken together with the Disclosure Package, did not, and at the Closing Time will not, contain any untrue statement of a material fact

or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they

were made, not misleading. The preceding sentence does not apply to statements in or omissions from the Company Additional Written Communication

based upon and in conformity with written information furnished to the Company by any Underwriter through the Representatives specifically

for use therein, it being understood and agreed that the only such information furnished by any Underwriter through the Representatives

consists of the Underwriter Information.

(tt)

IT Systems. The Company and its subsidiaries’ information technology assets and equipment, computers, systems, networks,

hardware, software, websites, applications, and databases (collectively, “IT Systems”) are adequate for, and operate

and perform as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, and

free and clear of all bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants, except where failure in the adequacy,

operation or performance of such IT Systems would not, individually or in the aggregate, result in a Material Adverse Effect. The Company

and its subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures, and safeguards designed to

maintain and protect their confidential information and the integrity, continuous operation, redundancy and security of all IT Systems

and data (including all personal, personally identifiable, sensitive, confidential or regulated data (“Personal Data”))

used in connection with their businesses, reasonably consistent with industry standards and practices, and, to the knowledge of the Company,

there have been no breaches, violations, outages or unauthorized uses of or accesses to same, nor any incidents under internal review

or investigations relating to the same, except where failure to implement or maintain such controls, policies, procedures and safeguards

or the occurrence of breaches, violations, outages or unauthorized uses or accesses would not, individually or in the aggregate, result

in a Material Adverse Effect. The Company and its subsidiaries are presently in compliance with all applicable laws or statutes and all

applicable judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies

and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems

and Personal Data from unauthorized use, access, misappropriation or modification, except where failure in compliance would not, individually

or in the aggregate, result in a Material Adverse Effect.

(uu)

Forward-Looking Statements. Each financial or operational projection or other “forward-looking statement” (as

defined by Section 27A of the Securities Act or Section 21E of the Exchange Act) contained in the Registration Statement, the

Disclosure Package and the Prospectus (i) was so included by the Company in good faith and with reasonable basis after due consideration

by the Company of the underlying assumptions, estimates and other applicable facts and circumstances, and (ii) is accompanied by

meaningful cautionary statements identifying those factors that could cause actual results to differ materially from those in such forward-looking

statement. No such statement was made with the knowledge of an executive officer or director of the Company that it was false or misleading.

(vv)

No Brokers. Other than as contemplated by this Agreement, there is no broker, finder or other party that is entitled to

receive from the Company or any subsidiary any brokerage or finder’s fee or any other fee, commission or payment as a result of

the transactions contemplated by this Agreement.

(ww) Deposit Insurance. The deposit accounts

of the Bank are insured by the FDIC up to applicable legal limits, the Bank has paid all premiums and assessments required by the FDIC

and the regulations thereunder, and no proceeding for the termination or revocation of such insurance is pending or, to the knowledge

of the Company, threatened.

(xx)

Derivative Instruments. Except as has not resulted in or would not reasonably be expected to result in a Material Adverse

Effect, any and all material swaps, caps, floors, futures, forward contracts, option agreements (other than options issued under the Company’s

shareholder-approved benefit plans) and other derivative financial instruments, contracts or arrangements, whether entered into for the

account of the Company or one of its subsidiaries or for the account of a customer of the Company or one of its subsidiaries, were entered

into in the ordinary course of business and in accordance with applicable laws, rules, regulations and policies of all applicable regulatory

agencies and with counterparties believed by the Company to be financially responsible. The Company and each of its subsidiaries have

duly performed in all material respects all of their obligations thereunder to the extent that such obligations to perform have accrued,

and there are no breaches, violations or defaults or allegations or assertions of such by any party thereunder except as could not, individually

or in the aggregate, have a Material Adverse Effect.

(yy)

Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Securities

as described in the Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Federal Reserve or any other

regulation of the Federal Reserve.

(zz)

Off-Balance Sheet Transactions. There is no transaction, arrangement or other relationship between the Company or any of

its subsidiaries and an unconsolidated or other off-balance sheet entity which is required to be disclosed in the Disclosure Package and

the Prospectus (other than as disclosed therein).

(aaa)

Contracts. The material contracts or agreements to which the Company or any of its subsidiaries is a party have been duly

and validly authorized, executed and delivered by the Company or its subsidiaries, as the case may be, and constitute the legal, valid

and binding agreements of the Company or its subsidiaries, enforceable by and against it in accordance with their respective terms, except

as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization or other similar laws relating to enforcement

of creditors’ rights generally, and general equitable principles relating to the availability of remedies, and subject to 12 U.S.C.

§ 1818(b)(6)(D) (or any successor statute) and similar bank regulatory powers and to the application of principles of public

policy, and except as rights to indemnity or contribution may be limited by federal or state securities laws and the public policy underlying

such laws. Except as would not reasonably be expected to have a Material Adverse Effect, neither the Company nor any subsidiary has sent

or received any communication regarding termination of, or intent not to renew, any of the material contracts or agreements, and no such

termination or non-renewal has been threatened by the Company or any subsidiary or, to the Company’s knowledge, any other party

to any such material contract or agreement; and there are no contracts or documents of the Company or any of its subsidiaries that are

required to be described in the Disclosure Package and the Prospectus or to be filed as exhibits thereto (or to the Registration Statement

or the documents incorporated or deemed to be incorporated by reference therein) by the Securities Act or by the rules and regulations

of the Commission thereunder that have not been so described and filed.

(bbb) Officer’s Certificates. Any

certificate signed by any officer of the Company or any of its subsidiaries delivered to the Representatives or to counsel for the Underwriters

pursuant to this Agreement shall be deemed a representation and warranty by the Company to each Underwriter as to the matters covered

thereby.

Section 2.

Sale and Delivery to Underwriters; Closing.

(a)

Securities. On the basis of the representations and warranties herein contained and subject to the terms and conditions

herein set forth, the Company agrees to sell to each Underwriter, severally and not jointly, and each Underwriter, severally and not jointly,

agrees to purchase from the Company, the aggregate principal amount of the Securities set forth opposite the name of such Underwriter

on Schedule I hereto, at a purchase price equal to 99.00% of the aggregate principal amount thereof.

(b)

Delivery. Delivery of the Securities shall be made at the offices of Skadden, Arps, Slate, Meagher & Flom LLP, 1 Manhattan

West, New York, New York 10001, or such other place as may be agreed to by the Representatives and the Company, and payment of the purchase

price for the Securities shall be made by the Representatives to the Company by wire transfer of immediately available funds contemporaneous

with closing at such place as shall be agreed upon by the Representatives and the Company, no later than 10:00 a.m. (New York City

time) on July 30, 2026, or such other time not later than ten (10) business days after such date as shall be agreed upon by the Representatives

and the Company (such time and date of payment and delivery being herein called the “Closing Time”). It is understood

that each Underwriter has authorized the Representatives, for its account, to accept delivery of, receipt for, and make payment of the

purchase price for, the Securities which it has agreed to purchase. KBW, individually and not as Representatives of the Underwriters,

may (but shall not be obligated to) make payment of the purchase price for the Securities to be purchased by any Underwriter whose funds

have not been received by the Closing Time, but such payment shall not relieve such Underwriter from its obligations hereunder.

(c)

Payment. Payment for the Securities purchased by the Underwriters shall be made to the Company by wire transfer of immediately

available funds to a bank designated by the Company, against delivery to the Representatives for the respective accounts of the Underwriters

of one or more global notes representing the Securities (collectively, the “Global Note”) to be purchased by the Underwriters.

The Securities represented by the Global Note shall be in such denominations and registered in such names as the Representatives may request

in writing at least one full business day prior to the Closing Time. The Global Note shall be made available for examination by the Representatives

not later than 10:00 a.m. (New York City time) on the business day prior to the Closing Time.

(d)

In performing its duties under this Agreement, the Underwriters shall be entitled to rely upon any notice, signature or writing

that the Underwriters shall in good faith believe to be genuine and to be signed or presented by a proper party or parties. The Underwriters

may rely upon any opinions or certificates or other documents delivered by the Company or its counsel or designees to them.

Section 3.

Covenants of the Company. The Company covenants with each Underwriter as follows:

(a)

Compliance with Commission Requests. Until the Closing Time, the Company, subject to SECTION 3(b) hereof, will comply

with the requirements of Rule 430B, and will notify the Representatives promptly, and confirm the notice in writing, (i) when

any post-effective amendment to the Registration Statement or any new registration statement relating to the Securities shall become effective

or any amendment or supplement to the Disclosure Package or the Prospectus shall have been used or filed, as the case may be, including

any document incorporated by reference therein, in each case only as permitted by SECTION 3 hereof, (ii) of the receipt of any

comments from the Commission, (iii) of any request by the Commission for any amendment to the Registration Statement or any amendment

or supplement to the Disclosure Package or the Prospectus, including any document incorporated by reference therein, or for additional

information, (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement

or any post-effective amendment thereto or any notice of objection to the use of the Registration Statement or any post-effective amendment

thereto pursuant to Rule 401(g)(2) or of the issuance of any order preventing or suspending the use of any preliminary prospectus

or the Prospectus or any amendment or supplement thereto, or of the suspension of the qualification of the Securities for offering or

sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of such purposes or of any examination pursuant

to Section 8(d) or 8(e) of the Securities Act concerning the Registration Statement and (v) if the Company becomes the subject

of a proceeding under Section 8A of the Securities Act in connection with the offering of the Securities. The Company will effect

all filings required under Rule 424(b), in the manner and within the time period required by Rule 424(b) (without reliance on

Rule 424(b)(8)), and will take such steps as it deems necessary to ascertain promptly whether the form of prospectus transmitted

for filing under Rule 424(b) was received for filing by the Commission and, in the event that it was not, it will promptly file such

prospectus. Until the Closing Time, the Company will make every reasonable effort to prevent the issuance of any stop, prevention or suspension

order and, if any such order is issued, to obtain the lifting thereof at the earliest possible moment.

(b)

Payment of Filing Fees. The Company shall pay the required Commission filing fees relating to the Securities within the

time required by Rule 456(b)(1)(i) under the Securities Act Regulations without regard to the proviso therein and otherwise in accordance

with Rules 456(b) and 457(r) under the Securities Act Regulations (including, if applicable, by updating the “Calculation of

Registration Fee” table in accordance with Rule 456(b)(1)(ii) either in a post-effective amendment to the Registration Statement

or on the cover page of a prospectus filed pursuant to Rule 424(b)).

(c)

Continued Compliance with Securities Laws. The Company will comply with the Securities Act, the Securities Act Regulations,

the Exchange Act, the Exchange Act Regulations, the TIA and the TIA Regulations so as to permit the completion of the distribution of

the Securities as contemplated in this Agreement and in the Registration Statement, the Disclosure Package and the Prospectus. If at any

time when a prospectus relating to the Securities is (or, but for the exception afforded by Rule 172 under the Securities Act Regulations,

would be) required by the Securities Act to be delivered in connection with sales of the Securities ending no later than nine (9) months

from the date hereof (the “Delivery Period”), any event shall occur or condition shall exist as a result of which it

is necessary, in the opinion of counsel for the Underwriters or for the Company, to (i) amend the Registration Statement in order

that the Registration Statement will not include an untrue statement of a material fact or omit to state a material fact required to be

stated therein or necessary to make the statements therein not misleading, (ii) amend or supplement the Disclosure Package or the

Prospectus in order that the Disclosure Package or the Prospectus, as the case may be, will not include any untrue statement of a material

fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of the circumstances

existing at the time it is delivered to a purchaser or (iii) amend the Registration Statement or amend or supplement the Disclosure

Package or the Prospectus, as the case may be, including, without limitation, any document incorporated therein by reference, in order

to comply with the requirements of the Securities Act, the Securities Act Regulations, the Exchange Act, the Exchange Act Regulations,

the TIA or the TIA Regulations, the Company will promptly (A) give the Representatives written notice of such event or condition,

(B) prepare any amendment or supplement as may be necessary to correct such statement or omission or to make the Registration Statement,

the Disclosure Package or the Prospectus comply with such requirements and, a reasonable amount of time prior to any proposed filing or

use, furnish the Representatives with copies of any such amendment or supplement and (C) file with the Commission any such amendment

or supplement and use its best efforts to have any amendment to the Registration Statement declared effective by the Commission as soon

as possible if the Company is no longer eligible to file an automatic shelf registration statement; provided that the Company shall not

file or use any such amendment or supplement to which the Representatives or counsel for the Underwriters shall object. If, after the

date of this Agreement and during any time when a prospectus is required by the Securities Act to be delivered (whether physically or

through compliance with Rule 172 under the Securities Act or any similar rule), the Company receives notice pursuant to Rule 401(g)(2)

under the Securities Act from the Commission or otherwise ceases to be eligible to use the automatic shelf registration form, the Company

shall promptly advise the Representatives in writing of such notice or ineligibility and will (1) promptly file a new registration

statement or post-effective amendment on the proper form relating to the Securities, (2) use its best efforts to cause such registration

statement or post-effective amendment to be declared effective by the Commission as soon as practicable and (3) promptly notify the

Representatives in writing of such effectiveness. If at any time during the Delivery Period, any event shall occur or condition shall

exist as a result of which the Disclosure Package or such Issuer Free Writing Prospectus, individually or together with other information

that is part of the Disclosure Package, as the case may be, conflicted or would conflict with the information contained in the Registration

Statement or any other registration statement relating to the Securities or included or would include an untrue statement of a material

fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances

prevailing at that subsequent time, not misleading, the Company will promptly notify the Representatives and will promptly amend or supplement,

at the Company’s own expense, the Disclosure Package or such Issuer Free Writing Prospectus, as the case may be, to eliminate or

correct such conflict, untrue statement or omission.

(d)

Filing or Use of Amendments or Supplements. During the Delivery Period, the Company (i) will furnish to the Representatives

for review, a reasonable period of time prior to the proposed time of filing of any proposed amendment or supplement to the Registration

Statement, a copy of each such amendment or supplement, and (ii) will not amend or supplement the Registration Statement without

the Representatives’ prior written consent, which consent shall not be unreasonably withheld or delayed. Prior to amending or supplementing

any preliminary prospectus or the Prospectus, the Company shall furnish to the Representatives for review, a reasonable amount of time

prior to the time of filing or use of the proposed amendment or supplement, a copy of each such proposed amendment or supplement. The

Company shall not file or use any such proposed amendment or supplement without the Representatives’ prior written consent, which

consent shall not be unreasonably withheld or delayed.

(e)

Delivery of Registration Statements. The Company has furnished or will deliver, upon request, to the Representatives and

counsel for the Underwriters, without charge, signed copies of the Registration Statement as originally filed and each amendment thereto

(including exhibits filed therewith or incorporated by reference therein and documents incorporated or deemed to be incorporated by reference

therein) and signed copies of all consents and certificates of experts, and will also deliver to the Representatives, upon request, without

charge, a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) for each of the

Underwriters. Any such signed copies of the Registration Statement and each amendment thereto furnished to the Underwriters will be identical

to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.

(f)

Delivery of Prospectuses. The Company has delivered to each Underwriter, without charge, as many copies of each preliminary

prospectus as such Underwriter reasonably requested, and the Company hereby consents to the use of such copies for purposes permitted

by the Securities Act. The Company will furnish to each Underwriter, without charge, during the Delivery Period, such number of copies

of the Prospectus (as amended or supplemented) as such Underwriter may reasonably request, unless, with the prior consent of the Representatives,

such delivery requirement can be satisfied by the provisions of Rule 172 under the Securities Act. The Prospectus and any amendments

or supplements thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the

Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.

(g)

Blue Sky Qualifications. The Company will use its best efforts, in cooperation with the Underwriters, to qualify the Securities

for offering and sale under the applicable securities laws of such states and non-U.S. jurisdictions as the Representatives may reasonably

designate and to maintain such qualifications in effect during the Delivery Period; provided that the Company shall not be obligated to

file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction

in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise

so subject.

(h)

Earnings Statements. The Company will timely file such reports pursuant to the Exchange Act as are necessary in order to

make generally available to its securityholders as soon as practicable an earnings statement for the purposes of, and to provide to the

Underwriters the benefits contemplated by, the last paragraph of Section 11(a) of the Securities Act.

(i)

Reporting Requirements. The Company, during the Delivery Period, will file all documents required to be filed with the Commission

by the Company pursuant to the Exchange Act within the time periods required by, and each such document will meet the requirements of,

the Exchange Act and the Exchange Act Regulations.

(j)

Use of Proceeds. The Company will use the net proceeds received by it from the sale of the Securities as described in the

Registration Statement, the Prospectus and the Disclosure Package under “Use of Proceeds.”

(k)

Issuer Free Writing Prospectuses. The Company agrees that, unless it obtains the prior written consent of the Representatives,

and each Underwriter agrees that, unless it obtains the prior written consent of the Company and the Representatives, it will not make

any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free

writing prospectus,” or a portion thereof, required to be filed by the Company with the Commission or retained by the Company under

Rule 433; provided that the Representatives will be deemed to have consented to any Issuer General Use Free Writing Prospectuses

listed on Schedule II hereto and any “road show that is a written communication” within the meaning of Rule 433(d)(8)(i)

that has been reviewed by the Representatives. The Company represents that it has treated or agrees that it will treat each such free

writing prospectus consented to, or deemed consented to, by the Representatives as an Issuer Free Writing Prospectus and that it has complied

and will comply with the applicable requirements of Rule 433 with respect thereto, including timely filing with the Commission where

required, legending and record keeping. If at any time following issuance of an Issuer Free Writing Prospectus during the Delivery Period

there occurred or occurs an event or condition as a result of which such Issuer Free Writing Prospectus included or would include an untrue

statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the

light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representatives in writing

and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to correct such untrue statement or omission.

Subject to the consent of the Representatives required

in the immediately preceding paragraph, the Company will prepare a final term sheet relating solely to the final pricing terms of the

Securities and will file such final term sheet within the period required by Rule 433(d)(5)(ii) following the date such final terms

have been established for such Securities. Any such final term sheet is an Issuer General Use Free Writing Prospectus for purposes of

this Agreement. Notwithstanding anything to the contrary contained herein, the Company consents to the use by any Underwriter of a free

writing prospectus that contains only (a) (i) information describing the preliminary terms of the Securities generally or the Securities

specifically or their offering or (ii) information that describes the final terms of the Securities or their offering and that is

or is to be included in the final term sheet of the Company contemplated in the first sentence of this paragraph or (b) other customary

information that is not “issuer information,” as defined in Rule 433.

(l)

DTC. The Company will cooperate with the Underwriters and use its best efforts to permit the Securities to be eligible for

clearance, settlement and trading through the facilities of DTC.

(m)

Investment Company Act. During the Delivery Period, the Company shall not invest or otherwise use the proceeds received

by the Company from the sale of the Securities in such a manner as could require the Company or any of the subsidiaries to register as

an investment company under the Investment Company Act.

(n)

No Stabilization. The Company will not take, and will ensure that no affiliate of the Company will take, directly or indirectly,

any action designed to cause or result in or which constitutes or might reasonably be expected to constitute stabilization or manipulation

of the price of the Securities or any reference security with respect to the Securities.

(o)

Trademarks. Upon request of any Underwriter, the Company will furnish, or cause to be furnished, to such Underwriter an

electronic version of the Company’s trademarks, service marks and corporate logo for use on the website, if any, operated by such

Underwriter for the purpose of facilitating the on-line offering of the Securities (the “License”); provided that the

License shall be used solely for the purpose described above, is granted without any fee and may not be assigned or transferred.

(p)

NRSRO Rating. The Company will use commercially reasonable efforts to maintain a rating by a “nationally recognized

statistical rating organization” as defined in Section 3(a)(62) of the Exchange Act (“NRSRO”) while any

Securities remain outstanding.

Section 4.

Payment of Expenses.

(a)

Expenses. Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated,

the Company covenants and agrees with the several Underwriters that the Company will pay or cause to be paid all expenses incident to

the performance of its obligations under this Agreement or the transactions contemplated hereby, including (i) the preparation, printing

and delivery to the Underwriters of this Agreement and such other documents as may be required in connection with the offering, purchase,

sale, issuance or delivery of the Securities, (ii) the delivery to the Underwriters of copies of each preliminary prospectus, each

Issuer Free Writing Prospectus and the Prospectus and any amendments or supplements thereto and any costs associated with electronic delivery

of any of the foregoing by the Underwriters to investors, (iii) the preparation, issuance and delivery of the Securities to the Underwriters,

(iv) the fees and disbursements of the Company’s counsel, accountants and other advisors, (v) the qualification of the

Securities under securities laws in accordance with the provisions of SECTION 3(g) hereof, including filing fees and the reasonable

fees and disbursements of counsel for the Underwriters in connection therewith and in connection with the preparation, printing and delivery

to the Underwriters of any Blue Sky Survey and any supplement thereto, and the fees and expenses of making the Securities eligible for

clearance, settlement and trading through the facilities of DTC, (vi) any fees payable in connection with the rating of the Securities,

(vii) the costs and expenses of the Company relating to investor presentations on any “road show” undertaken in connection

with the marketing of the Securities, including, without limitation, expenses associated with the production of road show slides and graphics,

fees and expenses of any consultants engaged in connection with the road show presentations, and any travel and lodging expenses of the

representatives and officers of the Company and any such consultants, (viii) any filing fees incident to, and the reasonable fees

and disbursements of counsel to the Underwriters incurred in connection with determining the Underwriters’ compliance with FINRA

rules and regulations applicable to their participation in the offering and the sale of the Securities, (ix) fees and disbursements of

the Trustee and its counsel and (x) the fees and expenses including, without limitation, the fees and expenses of the counsel for the

Underwriters, marketing and syndication expenses, and any expenses related to an investor presentation and/or roadshow that are incurred

by the Underwriters and (xi) all other costs and expenses incident to the performance of the obligations of the Company hereunder for

which provision is not otherwise made in this SECTION 4(a); provided that the aggregate amount of fees and expenses to be paid by

the Company pursuant to subclauses (v), (viii) and (x) herein shall not exceed $210,000.00 in the aggregate; provided that except

as provided in this Section, SECTION 7, SECTION 10(a) and SECTION 11 hereof, the Underwriters will pay all of their own

costs and expenses, including transfer taxes on resale of any of the Securities by them and the cost of preparing and distributing any

term sheet prepared by any Underwriter.

(b)

Termination of Agreement. If this Agreement is terminated by the Representatives in accordance with the provisions of SECTION 6,

SECTION 10(a) or SECTION 11 hereof, the Company shall reimburse the Underwriters for all of their out-of-pocket expenses, including

the reasonable and documented fees and expenses of counsel for the Underwriters.

Section 5.

Use of Free Writing Prospectuses by Underwriters. Each Underwriter represents and agrees that, unless it obtains the prior

consent of the Company and the Representatives, it has not made and will not make any offer relating to the Securities that would constitute

an Issuer Free Writing Prospectus, or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405,

required to be filed with the Commission.

Section 6.

Conditions of Underwriters’ Obligations. The obligations of the several Underwriters to purchase the Securities at

the Closing Time as provided herein are subject to the accuracy of the representations and warranties of the Company contained herein

or in certificates of any officer of the Company or any of its subsidiaries delivered pursuant to the provisions hereof, to the performance

by the Company of its covenants and other obligations hereunder, and to the following further conditions:

(a)

Effectiveness of Registration Statement, etc. The Registration Statement was filed by the Company with the Commission and

has been declared effective not earlier than three years prior to the date hereof. Each preliminary prospectus, each Issuer Free Writing

Prospectus and the Prospectus shall have been filed as required by Rule 424(b) (without reliance on Rule 424(b)(8)) and Rule 433,

as applicable, within the time period prescribed by, and in compliance with, the Securities Act Regulations. At the Closing Time, no stop

order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto shall have been issued under

the Securities Act or proceedings therefor initiated or threatened by the Commission, no notice of objection to the use of the Registration

Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) has been received by the Company, no order preventing

or suspending the use of any preliminary prospectus or the Prospectus or any amendment or supplement thereto has been issued and no proceedings

for any of those purposes have been instituted or are pending or, to the Company’s knowledge, contemplated. The Company has complied

with each request (if any) from the Commission for additional information with respect to the Registration Statement. The Company shall

have paid the required Commission filing fees relating to the Securities within the time period required by Rule 456(b)(1)(i) under

the Securities Act Regulations without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) under

the Securities Act Regulations and, if applicable, shall have updated the “Calculation of Registration Fee” table in accordance

with Rule 456(b)(1)(ii) either in a post-effective amendment to the Registration Statement or on the cover page of a prospectus filed

pursuant to Rule 424(b).

(b)

Opinion of Counsel for Company. At the Closing Time, the Representatives shall have received the favorable opinion, dated

as of the Closing Time, of Troutman Pepper Locke LLP, counsel for the Company, in form and substance reasonably satisfactory to the Representatives.

Such counsel may also state that, insofar as such opinion involves factual matters, they have relied, to the extent they deem proper,

upon certificates of officers and other representatives of the Company and its subsidiaries and certificates of public officials.

(c)

Opinion of Counsel for Underwriters. At the Closing Time, the Representatives shall have received the favorable opinion,

dated as of the Closing Time, of Skadden, Arps, Slate, Meagher & Flom LLP, counsel for the Underwriters, in form and substance reasonably

satisfactory to the Representatives. In giving such opinion, such counsel may rely, as to all matters governed by the laws of jurisdictions

other than the law of the State of New York and the federal securities laws of the United States, upon the opinion of counsel satisfactory

to the Representatives. Such counsel may also state that, insofar as such opinion involves factual matters, they have relied, to the extent

they deem proper, upon certificates of officers and other representatives of the Company and its subsidiaries and certificates of public

officials.

(d)

Officers’ Certificate of the Company. At the Closing Time, the Representatives shall have received a certificate of

the Chief Executive Officer or the President of the Company and of the chief financial or chief accounting officer of the Company, dated

as of the Closing Time, to the effect that (i) there has been no Material Adverse Effect, (ii) the representations and warranties

of the Company in this Agreement are true and correct with the same force and effect as though expressly made at and as of the Closing

Time, and (iii) the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied

at or prior to the Closing Time.

(e)

Comfort Letters. At the time of the execution of this Agreement, the Representatives shall have received from EY a letter,

dated as of such date, in form and substance reasonably satisfactory to the Representatives, containing statements and information of

the type ordinarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements

and financial information contained in the Registration Statement, the Disclosure Package and the Prospectus and the specified date referred

to therein shall be a date not more than two business days prior to the date of this Agreement.

(f)

Bring-down Comfort Letter. At the Closing Time, the Representatives shall have received from EY a letter, dated as of the

Closing Time, to the effect that they reaffirm the statements made in the letter furnished pursuant to SECTION 6(e) hereof, except

that the specified date referred to shall be a date not more than two business days prior to the Closing Time.

(g)

Certificate of the Chief Financial Officer. At the time of the execution of this Agreement, the Representatives shall have

received a certificate executed by the Chief Financial Officer, in form and substance reasonably satisfactory to the Representatives.

(h)

Bring-down Certificate of the Chief Financial Officer. At the Closing Time, the Representatives shall have received a certificate

executed by the Chief Financial Officer, in form and substance reasonably satisfactory to the Representatives.

(i)

Ratings. At the Closing Time, the Securities will be rated at least BBB by Kroll Bond Rating Agency, Inc. Subsequent to

the execution of this Agreement, there shall not have occurred a downgrading in or withdrawal of the rating assigned to the Securities

or any other securities of the Company by any NRSRO, and no such organization shall have publicly announced that it has under surveillance

or review, or has changed its outlook with respect to, its rating of the Securities or any other securities of the Company (other than

an announcement with positive implications of a possible upgrading).

(j)

DTC. At the Closing Time, the Securities shall be eligible for clearance, settlement and trading through the facilities

of DTC.

(k)

No Objection. If applicable, FINRA shall have raised no objection with respect to the fairness and reasonableness of the

underwriting terms and arrangements, which objection has not been withdrawn or otherwise satisfied.

(l)

Delivery of Prospectus. The Company shall have complied with the provisions hereof with respect to the furnishing of prospectuses,

in electronic or printed format, on the business day next succeeding the date of this Agreement.

(m)

No Termination Event. On or after the date hereof, there shall not have occurred any of the events, circumstances or occurrences

set forth in SECTION 10(a).

(n)

No Legal Impediment to Issuance and/or Sale. No action shall have been taken and no statute, rule, regulation or order shall

have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that remains in effect and

would, as of the Closing Time, prevent the issuance or sale of the Securities; and no injunction or order of any federal, state or foreign

court shall have been issued that remains in effect and would, as of the Closing Time, prevent the issuance or sale of the Securities.

(o)

Good Standing. The Representatives shall have received on and as of the Closing Time satisfactory evidence of the good standing

of the Company and the Bank in their respective jurisdictions of organization, in each case in writing or any standard form of telecommunication

from the appropriate governmental authorities of such jurisdictions.

(p)

Additional Documents. At the Closing Time, counsel for the Underwriters shall have been furnished with such documents, opinions

and certificates as they may reasonably require for the purpose of enabling them to pass upon the issuance and sale of the Securities

as herein contemplated, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of

the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Securities

as herein contemplated shall be in form and substance reasonably satisfactory to the Representatives and counsel for the Underwriters.

(q)

Termination of Agreement. If any condition specified in this SECTION 6 shall not have been fulfilled when and as required

to be fulfilled, this Agreement may be terminated by the Representatives by notice to the Company at any time prior to the Closing Time

and such termination shall be without liability of any party to any other party except as provided in SECTION 4 and except that SECTION 1,

SECTION 4, SECTION 7, SECTION 8, SECTION 9, SECTION 14, SECTION 15, SECTION 16 and SECTION 17

shall survive any such termination and remain in full force and effect.

Section 7.

Indemnification.

(a)

Indemnification of Underwriters. The Company agrees to indemnify and hold harmless each Underwriter and its respective affiliates

(as such term is defined in Rule 405 under the Securities Act Regulations (each, an “Affiliate”)), officers, partners,

managers, directors, employees and agents, and each person, if any, who controls any Underwriter within the meaning of Section 15

of the Securities Act or Section 20 of the Exchange Act as follows:

(i)

against any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue statement or

alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), including any information

deemed to be a part thereof pursuant to Rule 430B, or the omission or alleged omission therefrom of a material fact required to be

stated therein or necessary to make the statements therein not misleading or arising out of any untrue statement or alleged untrue statement

of a material fact included in any preliminary prospectus, any Issuer Free Writing Prospectus, the Disclosure Package or the Prospectus

(or any amendment or supplement thereto), or the omission or alleged omission from any preliminary prospectus, any Issuer Free Writing

Prospectus, the Disclosure Package or the Prospectus (or any amendment or supplement thereto) of a material fact necessary in order to

make the statements therein, in the light of the circumstances under which they were made, not misleading;

(ii)

against any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid

in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of

any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that

(subject to SECTION 7(d) hereof) any such settlement is effected with the written consent of the Company; and

(iii)

against any and all expense whatsoever, as incurred (including the fees and disbursements of counsel), reasonably incurred in investigating,

preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened,

or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent

that any such expense is not paid under (i) or (ii) above; provided that this indemnity agreement shall not apply to any loss, liability,

claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made in

the Registration Statement (or any amendment thereto), including any information deemed to be a part thereof pursuant to Rule 430B,

or in any preliminary prospectus, any Issuer Free Writing Prospectus, the Disclosure Package or the Prospectus (or any amendment or supplement

thereto) in reliance upon and in conformity with the Underwriter Information.

(b)

Indemnification of Company, Directors and Officers. Each Underwriter severally agrees to indemnify and hold harmless the

Company, each of the Company’s directors, each of the Company’s officers who signed the Registration Statement, and each person,

if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act against

any and all loss, liability, claim, damage and expense described in the indemnity contained in SECTION 7(a) hereof, as incurred,

but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement

(or any amendment thereto), including any information deemed to be a part thereof pursuant to Rule 430B, or in any preliminary prospectus,

any Issuer Free Writing Prospectus, the Disclosure Package or the Prospectus (or any amendment or supplement thereto) in reliance upon

and in conformity with the Underwriter Information.

(c)

Actions against Parties; Notification. Each indemnified party shall give notice as promptly as reasonably practicable to

each indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify

an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent it is not materially prejudiced

as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity

agreement. In the case of parties indemnified pursuant to SECTION 7(a) hereof, counsel to the indemnified parties shall be selected

by the Representatives, and, in the case of parties indemnified pursuant to SECTION 7(b) hereof, counsel to the indemnified parties

shall be selected by the Company. An indemnifying party may participate at its own expense in the defense of any such action or, if it

so elects within a reasonable time after receipt of such notice, to assume the defense of any suit brought to enforce any such claim;

but if it so elects to assume the defense, such defense shall be conducted by counsel chosen by it and approved by the indemnified parties,

which approval shall not be unreasonably withheld. In the event that an indemnifying party elects to assume the defense of any such suit

and retain such counsel, the indemnified party or parties shall bear the fees and expenses of any additional counsel thereafter retained

by such indemnified party or parties; provided, however, that the indemnified party or parties shall have the right to employ counsel

(in addition to local counsel) to represent the indemnified party or parties who may be subject to liability arising out of any action

in respect of which indemnity may be sought against the indemnifying party if (i) the employment of such counsel shall have been

authorized in writing by one of the indemnifying parties in connection with the defense of such action, or (ii) in the reasonable

judgment of counsel for the indemnified party or parties, there may be legal defenses available to such indemnified person which are different

from or in addition to those available to such indemnifying person, in which event the reasonable fees and expenses of appropriate separate

counsel shall be borne by the indemnifying party. In no event shall the indemnifying parties be liable for fees and expenses of more than

one counsel (in addition to any local counsel) separate from their own counsel for all indemnified parties in connection with any one

action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances.

No indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry

of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened,

or any claim whatsoever in respect of which indemnification or contribution could be sought under this SECTION 7 or SECTION 8

hereof (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent

(i) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation,

proceeding or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on

behalf of any indemnified party.

(d)

Settlement without Consent if Failure to Reimburse. If at any time an indemnified party shall have validly requested an

indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be

liable for any settlement of the nature contemplated by SECTION 7(a)(ii) effected without its written consent if (i) such settlement

is entered into more than 60 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party

shall have received notice of the terms of such settlement at least 45 days prior to such settlement being entered into and (iii) such

indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.

Section 8.

Contribution. If the indemnification provided for in SECTION 7 hereof is for any reason unavailable to or insufficient

to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each

indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such

indemnified party, as incurred, (i) in such proportion as is appropriate to reflect the relative benefits received by the Company,

on the one hand, and the Underwriters, on the other hand, from the offering of the Securities pursuant to this Agreement or (ii) if

the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only

the relative benefits referred to in clause (i) above but also the relative fault of the Company, on the one hand, and the Underwriters,

on the other hand, in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses,

as well as any other relevant equitable considerations.

The relative benefits received by the Company,

on the one hand, and the Underwriters, on the other hand, in connection with the offering of the Securities pursuant to this Agreement

shall be deemed to be in the same respective proportions as the total proceeds from the offering of the Securities pursuant to this Agreement

(before deducting expenses) received by the Company, on the one hand, and the total underwriting discounts received by the Underwriters,

on the other hand, in each case as set forth on the cover of the Prospectus, bear to the aggregate initial public offering price of the

Securities as set forth on the cover of the Prospectus.

The relative fault of the Company, on the one hand,

and the Underwriters, on the other hand, shall be determined by reference to, among other things, whether any such untrue or alleged untrue

statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or

by the Underwriters (it being understood and agreed that such information supplied by the Underwriters only consists of the Underwriter

Information), and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement

or omission.

The Company and the Underwriters agree that it

would not be just and equitable if contribution pursuant to this SECTION 8 were determined by pro rata allocation (even if the Underwriters

were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations

referred to above in this SECTION 8. The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified

party and referred to above in this SECTION 8 shall be deemed to include any legal or other expenses reasonably incurred by such

indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental

agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or

alleged omission.

Notwithstanding any other provision of this SECTION 8,

no Underwriter shall be required to contribute any amount in excess of the underwriting discount received by such Underwriter in connection

with the Securities underwritten by it and distributed to the public.

No person guilty of fraudulent misrepresentation

(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty

of such fraudulent misrepresentation. The Underwriters’ respective obligations to contribute pursuant to this SECTION 8 are

several in proportion to their respective underwriting obligations set forth opposite their respective names in Schedule I

hereto and not joint.

For purposes of this SECTION 8, each person,

if any, who controls an Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act

and each Underwriter’s Affiliates, officers, directors, partners, managers, employees and agents shall have the same rights to contribution

as such Underwriter; and each director of the Company, each officer of the Company who signed the Registration Statement, and each person,

if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall

have the same rights to contribution as the Company.

Section 9.

Representations, Warranties and Agreements to Survive. All representations, warranties and agreements contained in this

Agreement or in certificates of officers of the Company or any of its subsidiaries submitted pursuant hereto shall remain operative and

in full force and effect regardless of (i) any investigation made by or on behalf of any Underwriter or its Affiliates, officers,

directors, employees, agents, any person controlling any Underwriter or the Company’s officers or directors or any person controlling

the Company and (ii) delivery of and payment for the Securities.

Section 10.

Termination of Agreement.

(a)

Termination. The Representatives may terminate this Agreement, by notice to the Company, at any time at or prior to the

Closing Time, (i) if there has been, in the judgment of the Representatives, since the time of execution of this Agreement or since

the respective dates as of which information is given in the Registration Statement, the Disclosure Package or the Prospectus, any Material

Adverse Effect, (ii) if there has occurred any material adverse change in the financial markets in the United States or the international

financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis, including a widespread outbreak of epidemic

illnesses (including the novel coronavirus COVID-19 to the extent that there is a material worsening of such outbreak that actually occurs

after the date hereof in the markets in which the Company operates), or any change or development involving a prospective change in national

or international political, financial or economic conditions, including, without limitation, as a result of terrorist activities, in each

case the effect of which is such as to make it, in the judgment of the Representatives, impracticable or inadvisable to proceed with the

completion of the offering of the Securities on the terms and in the manner contemplated in the Registration Statement, the Prospectus

and the Disclosure Package, to market the Securities or to enforce contracts for the sale of the Securities, (iii) if trading in

any securities of the Company has been suspended or materially limited by the Commission or by the Nasdaq Global Select Market, (iv) if

trading generally on the New York Stock Exchange or the Nasdaq Global Select Market has been suspended or materially limited, or minimum

or maximum prices for trading have been fixed, or maximum ranges for prices have been required, by any of said exchanges or by order of

the Commission, FINRA or any other governmental agency or body, (v) if a material disruption has occurred in commercial banking or

securities settlement or clearance services in the United States or with respect to Clearstream or Euroclear systems in Europe, (vi) if

there has occurred a downgrading in or withdrawal of the rating assigned to the Securities or any other securities of the Company by any

NRSRO, or such organization has publicly announced that it has under surveillance or review, or has changed its outlook with respect to,

its rating of the Securities or any other securities of the Company, or (vii) if a banking moratorium has been declared by United

States, New York or Virginia authorities.

(b)

Liabilities. If this Agreement is terminated pursuant to this Section, such termination shall be without liability of any

party to any other party except as provided in SECTION 4 hereof, and provided further that SECTION 1, SECTION 4, SECTION 7,

SECTION 8, SECTION 9, SECTION 14, SECTION 15, SECTION 16 and SECTION 17 shall survive such termination and

remain in full force and effect.

Section 11.

Default by One or More of the Underwriters.

(a)

If one or more of the Underwriters shall fail at the Closing Time to purchase the Securities that they have agreed to purchase

hereunder (the “Defaulted Securities”), the Representatives shall have the right, within 24 hours thereafter, to make

arrangements for one or more of the non-defaulting Underwriters, or any other underwriters that are satisfactory to the Company, to purchase

all, but not less than all, of the Defaulted Securities in such amounts as may be agreed upon and upon the terms herein set forth; if,

however, the Representatives shall not have completed such arrangements within such 24-hour period, then:

(i)

if, after giving effect to any arrangement for the purchase of the Securities of a defaulting Underwriter or Underwriters by the

non-defaulting Underwriters and the Company as provided in paragraph (a) above, the aggregate principal amount of such Securities

that remains unpurchased does not exceed 10% of the aggregate principal amount of all of the Securities, then the Company shall have the

right to require each non-defaulting Underwriter to purchase the aggregate principal amount of Securities that such Underwriter agreed

to purchase hereunder plus such Underwriter’s pro rata share (based on the aggregate principal amount of Securities that such Underwriter

agreed to purchase hereunder) of the Securities of such defaulting Underwriter or Underwriters for which such arrangement has not been

made, or

(ii)

if, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the

non-defaulting Underwriters and the Company as provided in paragraph (a) above, the aggregate principal amount of such Securities

that remains unpurchased exceeds 10% of the aggregate principal amount of all of the Securities, or if the Company shall not exercise

the right described in paragraph (a) above, then this Agreement shall terminate without liability on the part of the non-defaulting

Underwriters. Any termination of this Agreement pursuant to this SECTION 11 shall be without liability on the part of the Company,

except that the Company will continue to be liable for the payment of expenses as set forth in SECTION 4 hereof and except that the

provisions of SECTION 1, SECTION 4, SECTION 7, SECTION 8, SECTION 9, SECTION 14, SECTION 15, SECTION 16

and SECTION 17 shall not terminate and shall remain in effect.

(b)

No action taken pursuant to this SECTION 11 shall relieve any defaulting Underwriter from liability in respect of its default.

In the event of any such default which does not result in a termination of this Agreement, either (i) the Representatives or (ii) the

Company shall have the right to postpone the Closing Time for a period not exceeding five business days in order to effect any required

changes in the Registration Statement, the Disclosure Package or the Prospectus or in any other documents or arrangements. As used herein,

the term “Underwriter” includes any person substituted for an Underwriter under this SECTION 11.

Section 12.

Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given

if mailed or transmitted by any standard form of telecommunication. Notices to the Underwriters shall be directed to (i) Keefe, Bruyette

& Woods, Inc., 787 Seventh Avenue, 4th Floor, New York, New York 10019, e-mail: USCapitalMarkets@kbw.com, and (ii) Piper Sandler

& Co., 1251 Avenue of the Americas, 6th Floor, New York, New York 10020, Attention: Legal Department, with a copy (which shall not

constitute notice) to Skadden, Arps, Slate, Meagher & Flom LLP, 1 Manhattan West, New York, New York 10001, attention of Michael P.

Reed, e-mail: michael.reed@skadden.com; and notices to the Company shall be directed to it at 4355 Innslake Drive, Glen Allen, Virginia

23060, attention of John Tull, Corporate Treasurer, e-mail: John.Tull@atlanticunionbank.com and attention of Rachael Lape, General Counsel,

e-mail: Rachael.Lape@atlanticunionbank.com, with a copy (which shall not constitute notice) to Troutman Pepper Locke LLP, 1001 Haxall

Point, 15th Floor, Richmond, Virginia 23219, attention of Seth Winter, e-mail: seth.winter@troutman.com.

Section 13.

No Advisory or Fiduciary Relationship. The Company acknowledges and agrees that (a) the offering or purchase and sale

of the Securities pursuant to this Agreement, including the determination of the terms of the Securities and the offering price thereof

and any related discounts and commissions, is an arm’s-length commercial transaction between the Company, on the one hand, and the

several Underwriters, on the other hand, (b) in connection with the offering of the Securities and the process leading thereto, each

Underwriter is and has been acting solely as a principal and is not the agent or fiduciary of the Company or any of its subsidiaries or

their respective shareholders, creditors, employees or any other party, (c) no Underwriter has assumed or will assume an advisory

or fiduciary responsibility in favor of the Company or its subsidiaries in connection with the offering of the Securities or the process

leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company or any of its subsidiaries

on other matters) or any other obligation to the Company or its subsidiaries in connection with the offering of the Securities except

the obligations expressly set forth in this Agreement, (d) the Underwriters and their respective Affiliates may be engaged in a broad

range of transactions that involve interests that differ from those of the Company or its subsidiaries, and (e) the Underwriters

have not provided any legal, accounting, financial, regulatory or tax advice in connection with the offering of the Securities and the

Company and its subsidiaries have consulted their own respective legal, accounting, financial, regulatory and tax advisors to the extent

they deemed appropriate.

Section 14.

Parties. This Agreement shall inure to the benefit of and be binding upon the Underwriters, the Company, and their respective

successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or corporation,

other than the Underwriters, the Company, and their respective successors and the controlling persons, Affiliates, partners, managers,

employees, agents, officers and directors referred to in SECTION 7 and SECTION 8 and their heirs and legal representatives,

any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision herein contained. This Agreement

and all conditions and provisions hereof are intended to be for the sole and exclusive benefit of the Underwriters, the Company, and their

respective successors, and said controlling persons, Affiliates, employees, agents, officers and directors and their heirs and legal representatives,

and for the benefit of no other person, firm or corporation. No purchaser of Securities from any Underwriter shall be deemed to be a successor

by reason merely of such purchase.

Section 15.

Trial by Jury. Each of the Company (on its behalf and, to the extent permitted by applicable law, on behalf of its shareholders

and affiliates) and each Underwriter hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to

trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.

Section 16.

GOVERNING LAW. THIS AGREEMENT, ANY TRANSACTION CONTEMPLATED HEREUNDER, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER

OR RELATED TO THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD

TO CONFLICTS OF LAW PRINCIPLES THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAWS OF THE STATE OF NEW YORK.

Section 17.

Consent to Jurisdiction. Each of the parties hereto agrees that any legal suit, action or proceeding arising out of or based

upon this Agreement or the transactions contemplated hereby shall be instituted in (i) the federal courts of the United States of

America located in the City and County of New York, Borough of Manhattan or (ii) the courts of the State of New York located in the

City and County of New York, Borough of Manhattan (collectively, the “Specified Courts”), and irrevocably submits to

the exclusive jurisdiction of, and to venue in (except for proceedings instituted in regard to the enforcement of a judgment of any Specified

Court, as to which such jurisdiction is non-exclusive) the Specified Courts in any such suit, action or proceeding. Service of any process,

summons, notice or document by mail to such party’s address set forth herein shall be effective service of process for any suit,

action or proceeding brought in any Specified Court. Each of the parties hereto irrevocably and unconditionally waives any objection to

the laying of venue of any suit, action or proceeding in the Specified Courts and irrevocably and unconditionally waives and agrees not

to plead or claim in any Specified Court that any such suit, action or proceeding brought in any Specified Court has been brought in an

inconvenient forum.

Section 18.

TIME. TIME SHALL BE OF THE ESSENCE OF THIS AGREEMENT. EXCEPT AS OTHERWISE SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER

TO NEW YORK CITY TIME.

Section 19.

Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original,

but all such counterparts shall together constitute one and the same Agreement. The exchange of copies of this Agreement and of signature

pages by facsimile or other electronic means shall constitute effective execution and delivery of this Agreement by the parties hereto

and may be used in lieu of the original signature pages to this Agreement for all purposes.

Section 20.

Effect of Headings. The Section headings herein are for convenience only and shall not affect the construction hereof.

Section 21.

Entire Agreement; Amendments. This Agreement constitutes the entire Agreement of the parties to this Agreement and supersedes

all prior written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter

hereof. This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein (express

or implied) may be waived unless waived in writing by each party that the condition is meant to benefit.

[Signature pages follow]

Very truly yours,

ATLANTIC UNION BANKSHARES CORPORATION

By:

/s/ Alexander D. Dodd

Name:

Alexander D. Dodd

Title:

Executive Vice President and Chief Financial Officer

CONFIRMED AND ACCEPTED,

as of the date first above written:

KEEFE, BRUYETTE & WOODS, INC.

By:

/s/ Scott Anderson

Name:

Scott Anderson

Title:

Head, Investment Banking

PIPER SANDLER & CO.

By:

/s/ James Furey

Name:

James Furey

Title:

Managing Director

For themselves and as Representatives of the other Underwriters named

in Schedule I hereto.

[Signature Pages to Underwriting Agreement]

SCHEDULE I

Name of Underwriter

Aggregate

Principal

Amount of Securities to

be Purchased

Keefe, Bruyette & Woods, Inc.

$150,000,000

Piper Sandler & Co.

100,000,000

Total

$250,000,000.00

SCHEDULE II

Issuer Free Writing Prospectuses

Pricing Term Sheet for Securities, dated July 27, 2026.

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

Jul. 27, 2026

Document Information [Line Items]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jul. 27, 2026

Entity File Number

001-39325

Entity Registrant Name

ATLANTIC

UNION BANKSHARES CORPORATION

Entity Central Index Key

0000883948

Entity Tax Identification Number

54-1598552

Entity Incorporation, State or Country Code

Entity Address, Address Line One

4300

Cox Road

Entity Address, City or Town

Glen

Allen

Entity Address, State or Province

Entity Address, Postal Zip Code

23060

City Area Code

(804)

Local Phone Number

633-5031

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

false

Common Stock [Member]

Document Information [Line Items]

Title of 12(b) Security

Common

Stock, par value $1.33 per share

Trading Symbol

AUB

Security Exchange Name

NYSE

Series A Preferred Stock [Member]

Document Information [Line Items]

Title of 12(b) Security

Depositary

Shares, Each Representing a 1/400th Interest in a Share of 6.875% Perpetual Non-Cumulative Preferred Stock, Series A

Trading Symbol

AUB.PRA

Security Exchange Name

NYSE

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:

dei_DocumentInformationLineItems

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: